Abstract: The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.
Type:
Grant
Filed:
November 12, 1999
Date of Patent:
February 27, 2001
Assignee:
NYXIS NeuroTherapies, Inc.
Inventors:
Roger A. Kroes, Joseph R. Moskal, Hirotaka Yamamoto